Investor Alert – Asterias Biotherapeutics
Are you concerned about your investment in Asterias Biotherapeutics? If so, the securities attorneys at The White Law Group may be able to help you by filing a FINRA Arbitration claim against the brokerage firm that sold you the investment.
Asterias Biotherapeutics, Inc. (NYSE MKT:AST) is a biotechnology company dedicated to developing cell-based therapeutics to treat neurological conditions associated with demyelination and cellular immunotherapies to treat cancer, according to reports.
The company, based in Fremont, CA, reported a loss of $2.3 million in its first quarter, on May 9. Asterias said it had a loss of 4 cents per share. Losses, adjusted for non-recurring gains, were 9 cents per share.
According to Yahoo Finance, in the final minutes of trading on May 9, the company’s shares hit $1.30. A year ago, they were trading at $3.15.
Free Consultation with a Securities Attorney
The White Law Group is investigating the liability that FINRA registered brokerage firms may have for improperly recommending Asterias Biotherapeutics to investors.
Broker dealers are required to perform adequate due diligence on any investment they recommend and to ensure that all recommendations are suitable for the investor. Firms that fail to do so, may be held responsible for any losses in a FINRA arbitration claim.
FINRA can help resolve problems and disputes through two non-judicial proceedings: arbitration and mediation. FINRA’s Dispute Resolution forum handles nearly all of the securities-related arbitrations and mediations in the United States.
If you have concerns regarding your investment in Asterias Biotherapeutics and would like to speak with a securities attorney about your options, please call The White Law Group at 888-637-5510.
The White Law Group, LLC is a national securities fraud, securities arbitration, investor protection, and securities regulation/compliance law firm with offices in Chicago, Illinois and Franklin, Tennessee.
For more information on The White Law Group and its representation of investors in FINRA arbitration claims, visit https://whitesecuritieslaw.com.
Tags: Asterias Biotherapeutics, Asterias Biotherapeutics complaints, Asterias Biotherapeutics default, Asterias Biotherapeutics help, Asterias Biotherapeutics high commissions, Asterias Biotherapeutics information, Asterias Biotherapeutics investigation, Asterias Biotherapeutics investment, Asterias Biotherapeutics investment losses, Asterias Biotherapeutics investor relations, Asterias Biotherapeutics investors, Asterias Biotherapeutics losses, Asterias Biotherapeutics ppm, Asterias Biotherapeutics private placement, Asterias Biotherapeutics prospectus, Asterias Biotherapeutics recovery options, Asterias Biotherapeutics risk, Asterias Biotherapeutics stock information, Asterias Biotherapeutics update Last modified: May 22, 2018